The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system
Open accessAbstract
In 2019-2020 a new coronavirus named SARS-CoV-2 was identified as the causative agent of a several acute respiratory infection named COVID-19, which is causing a worldwide pandemic. There are still many unresolved questions regarding the pathogenesis of this disease and especially the reasons underlying the extremely different clinical course, ranging from asymptomatic forms to severe manifestations, including the Acute Respiratory Distress Syndrome (ARDS). SARS-CoV-2 showed phylogenetic similarities to both SARS-CoV and MERS-CoV viruses, and some of the clinical features are shared between COVID-19 and previously identified beta-coronavirus infections. Available evidence indicate that the so called "cytokine storm" an uncontrolled over-production of soluble markers of inflammation which, in turn, sustain an aberrant systemic inflammatory response, is a major responsible for the occurrence of ARDS. Chemokines are low molecular weight proteins with powerful chemoattractant activity which play a role in the immune cell recruitment during inflammation. This review will be aimed at providing an overview of the current knowledge on the involvement of the chemokine/chemokine-receptor system in the cytokine storm related to SARS-CoV-2 infection. Basic and clinical evidences obtained from previous SARS and MERS epidemics and available data from COVID-19 will be taken into account.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
T helper (Th)-1 and Th-2 cytokines are elevated in the serum of COVID-19 patients in a cytokine storm typically associated with the illness.
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically associated with the illness.”
From Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up (2021) · cites this paper as Coperchini et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246 · see citing works
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545 · see citing works
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332 · see citing works
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970 · see citing works
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532 · see citing works
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,784 · see citing works
The reproductive number of COVID-19 is higher compared to SARS coronavirus
Liu, Y., Gayle, A. A., Wilder‐Smith, A., & Rocklöv, J. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa021 · Cited by 3,169 · see citing works
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620 · see citing works
Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works
IL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · see citing works
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works
Henry, B. M., de Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0369 · Cited by 1,964 · see citing works
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,963 · see citing works
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works
Zhang, C., Wu, Z., Li, J., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758 · see citing works
McGonagle, D., Sharif, K., O'Regan, A., & Bridgewood, C. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102537 · Cited by 1,654 · see citing works
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,605 · see citing works
Channappanavar, R., Fehr, A. R., Vijay, R., Mack, M., Zhao, J., Meyerholz, D. K., & Perlman, S. M. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.007 · Cited by 1,400 · see citing works
The Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,377 · see citing works
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305 · see citing works
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
Wong, C. K., LAM, C. W. K., Wu, A. K. L., Ip, W., Lee, N. L. S., Chan, I., Lit, L. C. W., Hui, D. S. C., Chan, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,270 · see citing works
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154 · see citing works
Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., Guo, D., Hu, W., Yang, J., Tang, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1747363 · Cited by 1,076 · see citing works
Bachelerie, F., Ben‐Baruch, A., Burkhardt, A. M., Combadière, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre‐Ulrich, A. H., Locati, M., Luster, A. D., et al. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 846 · see citing works
[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].
Chen, L., Liu, H., Liu, W. Y., Liu, J., Liu, K., Shang, J., Deng, Y., & Wei, S. (2020) · PubMed · doi:10.3760/cma.j.issn.1001-0939.2020.0005 · Cited by 690 · see citing works
The interferon response circuit: Induction and suppression by pathogenic viruses
Haller, O., Kochs, G., & Weber, F. (2005) · Virology · doi:10.1016/j.virol.2005.09.024 · Cited by 679 · see citing works
An interferon‐γ‐related cytokine storm in SARS patients
Huang, K., Su, I., Theron, M., Wu, Y., Lai, S., Liu, C., & Lei, H. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20255 · Cited by 679 · see citing works
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
Donnelly, S. C., Haslett, C., Strieter, R. M., Kunkel, S. L., Walz, A., Robertson, C. R., Carter, D. C., Pollok, A., & Grant, I. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90416-e · Cited by 674 · see citing works
Kopecky-Bromberg, S. A., Martínez‐Sobrido, L., Frieman, M. B., Baric, R. S., & Palese, P. (2006) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 662 · see citing works
Chu, H., Chan, J. F., Wang, Y., Yuen, T. T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa410 · Cited by 659 · see citing works
Links between innate and adaptive immunity via type I interferon
Bon, A. L., & Tough, D. F. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00354-0 · Cited by 582 · see citing works
Viral mimicry of cytokines, chemokines and their receptors
Alcamı́, A. (2003) · Nature reviews. Immunology · doi:10.1038/nri980 · Cited by 560 · see citing works
The laboratory tests and host immunity of COVID-19 patients with different severity of illness
Wang, F., Hou, H., Luo, Y., Tang, G., Wu, S., Huang, M., Liu, W., Zhu, Y., Lin, Q., Mao, L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137799 · Cited by 550 · see citing works
Inflammatory Cytokines in Patients With Persistence of the Acute Respiratory Distress Syndrome
Goodman, R. B., Strieter, R. M., Martin, D. P., Steinberg, K. P., MILBERG, J. A., Maunder, R. J., Kunkel, S. L., Walz, A., Hudson, L. D., & Martin, T. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810593 · Cited by 528 · see citing works
Frieman, M. B., Yount, B. L., Heise, M. T., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 508 · see citing works
Snijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J. C., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 506 · see citing works
Miller, E. J., Cohen, A. B., Nagao, S., Griffith, D. E., Maunder, R. J., Martin, T. R., Weiner-Kronish, J. P., Sticherling, M., Christophers, E., & Matthay, M. A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.2.427 · Cited by 472 · see citing works
Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells
Law, H., Cheung, C. Y., Ng, H. Y., Sia, S. F., Chan, Y. O., Luk, W., Nicholls, J. M., Peiris, M. J. S., & Lau, Y. (2005) · Blood · doi:10.1182/blood-2004-10-4166 · Cited by 467 · see citing works
Coronavirus Replication Complex Formation Utilizes Components of Cellular Autophagy
Prentice, E., Jerome, W. G., Yoshimori, T., Mizushima, N., & Denison, M. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306124200 · Cited by 450 · see citing works
Zhou, J., Chu, H., Li, C., Wong, B. H., Cheng, Z., Poon, V. K., Sun, T., Lau, C. C.-Y., Wong, K. K. Y., Chan, J. Y. W., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 425 · see citing works
The mercurial nature of neutrophils: still an enigma in ARDS?
Williams, A. E., & Chambers, R. C. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00311.2013 · Cited by 418 · see citing works
Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms.
Folkesson, H. G., Matthay, M. A., Hébert, C. A., & Broaddus, V. C. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118009 · Cited by 416 · see citing works
DeDiego, M. L., Nieto-Torres, J. L., Regla-Nava, J. Á., Jiménez-Guardeño, J. M., Fernández‐Delgado, R., Fett, C., Castaño-Rodríguez, C., Perlman, S. M., & Enjuanes, L. (2013) · Journal of Virology · doi:10.1128/jvi.02576-13 · Cited by 395 · see citing works
Ward, S. G., Bacon, K. B., & Westwick, J. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80583-x · Cited by 394 · see citing works
One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers
Leung, T., Hoffmann, A., & Baltimore, D. (2004) · Cell · doi:10.1016/j.cell.2004.08.007 · Cited by 393 · see citing works
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391 · see citing works
Evolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368 · see citing works
Chemokine/Chemokine Receptor Nomenclature
Bacon, K. B., Baggiolini, M., Broxmeyer, H. E., Horuk, R., Lindley, I., Mantovani, A., Maysushima, K., Murphy, P. M., Nomiyama, H., Oppenheim, J. J., et al. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760624305 · Cited by 359 · see citing works
Transepithelial Migration of Neutrophils
Zemans, R. L., Colgan, S. P., & Downey, G. P. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0348tr · Cited by 339 · see citing works
Interleukin-6 as a potential biomarker of COVID-19 progression
Ulhaq, Z. S., & Soraya, G. V. (2020) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2020.04.002 · Cited by 333 · see citing works
Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S.-Q., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 317 · see citing works
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome
Reghunathan, R., Jayapal, M., Hsu, L. Y., Chng, H. H., Tai, D. Y. H., Leung, B. P. L., & Melendez, A. J. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-2 · Cited by 295 · see citing works
Interleukin-6 and its receptor: from bench to bedside
Scheller, J., & Rose‐John, S. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0019-9 · Cited by 292 · see citing works
Ichikawa, A., Kuba, K., Morita, M., Chida, S., Tezuka, H., Hara, H., Sasaki, T., Ohteki, T., Ranieri, V. M., dos Santos, C. C., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0508oc · Cited by 289 · see citing works
Role of Chemokines in the Pathogenesis of Acute Lung Injury
Bhatia, M., Zemans, R. L., & Jeyaseelan, S. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0392tr · Cited by 274 · see citing works
Zhao, J., Zhao, J., Legge, K., & Perlman, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59777 · Cited by 265 · see citing works
Chemokine and chemotactic signals in dendritic cell migration
Tiberio, L., Prete, A. D., Schioppa, T., Sozio, F., Bosisio, D., & Sozzani, S. (2018) · Cellular and Molecular Immunology · doi:10.1038/s41423-018-0005-3 · Cited by 257 · see citing works
Role of Chemokines in Endocrine Autoimmune Diseases
Rotondi, M., Chiovato, L., Romagnani, S., Serio, M., & Romagnani, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0044 · Cited by 254 · see citing works
Self-citationCytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 252 · see citing works
Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?
Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, É., Titécat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 249 · see citing works
SARS coronavirus and innate immunity
Frieman, M. B., Heise, M. T., & Baric, R. S. (2007) · Virus Research · doi:10.1016/j.virusres.2007.03.015 · Cited by 236 · see citing works
Inverse Interference: How Viruses Fight the Interferon System
Weber, F., Kochs, G., & Haller, O. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.498 · Cited by 212 · see citing works
Melchjorsen, J., Sørensen, L. N., & Paludan, S. R. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102577 · Cited by 209 · see citing works
Chemokine/chemokine receptor nomenclature
Nomenclature, I. S. O. C. (2003) · Cytokine · doi:10.1016/s1043-4666(02)00493-3 · Cited by 198 · see citing works
The interferon in TLR signaling: more than just antiviral
Hertzog, P. J., O'Neill, L. A. J., & Hamilton, J. A. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.08.006 · Cited by 196 · see citing works
Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
Kim, E. S., Choe, P. G., Park, W. B., Oh, H. S., Kim, E. J., Nam, E. Y., Na, S. H., Kim, M., Song, K., Bang, J. H., et al. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.11.1717 · Cited by 193 · see citing works
Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., Lin, X., Poon, V. K., Sun, T., Lau, C. C.-Y., Chan, J. F., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 178 · see citing works
Fremont, R. D., Koyama, T., Calfee, C. S., Wu, W. K. K., Dossett, L. A., Bossert, F. R., Mitchell, D. B., Wickersham, N. E., Bernard, G. R., Matthay, M. A., et al. (2010) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181c40728 · Cited by 169 · see citing works
Pathogenesis of severe acute respiratory syndrome
Lau, Y., & Peiris, M. J. S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.05.009 · Cited by 168 · see citing works
Human infection by avian influenza A H5N1.
Yuen, K., & Wong, S. S. Y. (2005) · PubMed · Cited by 167 · see citing works
Tseng, C.-T. K., Perrone, L. A., Zhu, H., Makino, S., & Peters, C. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7977 · Cited by 152 · see citing works
Interferon and cytokine responses to SARS-coronavirus infection
Thiel, V., & Weber, F. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.001 · Cited by 149 · see citing works
Chang, Y., Liu, C. Y. Y., Chiang, B., Chao, Y., & Chen, C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7602 · Cited by 131 · see citing works
Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells
Spiegel, M., Schneider, K., Weber, F., Weidmann, M., & Hufert, F. T. (2006) · Journal of General Virology · doi:10.1099/vir.0.81624-0 · Cited by 130 · see citing works
Virus classification – where do you draw the line?
Simmonds, P., & Aiewsakun, P. (2018) · Archives of Virology · doi:10.1007/s00705-018-3938-z · Cited by 129 · see citing works
Activation of AP-1 signal transduction pathway by SARS coronavirus nucleocapsid protein
He, R., Leeson, A., Andonov, A. P., Li, Y., Bastien, N., Cao, J., Osiowy, C., Dobie, F. A., Cutts, T. A., Ballantine, M., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.075 · Cited by 121 · see citing works
Serum IP-10 as a Biomarker of Human Rhinovirus Infection at Exacerbation of COPD
Quint, J. K., Donaldson, G. C., Goldring, J. J. P., Baghai-Ravary, R., Hurst, J. R., & Wedzicha, J. A. (2009) · CHEST Journal · doi:10.1378/chest.09-1541 · Cited by 121 · see citing works
Biomarkers for the acute respiratory distress syndrome: how to make the diagnosis more precise
García-Laorden, M. I., Lorente, J. A., Flores, C., Slutsky, A. S., & Villar, J. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.49 · Cited by 118 · see citing works
Calfee, C. S., Ware, L. B., Glidden, D. V., Eisner, M. D., Parsons, P. E., Thompson, B., & Matthay, M. A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318207ec3c · Cited by 114 · see citing works
Aisiku, I. P., Yamal, J., Doshi, P., Benoit, J. S., Gopinath, S. P., Goodman, J. C., & Robertson, C. S. (2016) · Critical Care · doi:10.1186/s13054-016-1470-7 · Cited by 114 · see citing works
SARS-CoV and IFN: Too Little, Too Late
Kindler, E., & Thiel, V. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.01.012 · Cited by 102 · see citing works
Friedman, R. M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03055.x · Cited by 95 · see citing works
Ng, L. F. P., Hibberd, M. L., Ooi, E. E., Tang, K. F., Neo, S.-Y., Tan, J. S., Murthy, K. R. K., Vega, V. B., Chia, J.-M., Liu, E. T., et al. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-34 · Cited by 88 · see citing works
Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus
Cinatl, J. J., Hoever, G., Morgenstern, B., Preiser, W., Vogel, J., Hofmann, W.-K., Bauer, G., Michaelis, M., Rabenau, H. F., & Doerr, H. W. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4222-9 · Cited by 86 · see citing works
Agrawal, A. T., Zhuo, H., Brady, S. E., Levitt, J. E., Steingrub, J. S., Siegel, M. D., Soto, G. J., Peterson, M. W., Chesnutt, M. S., Matthay, M. A., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00195.2012 · Cited by 86 · see citing works
Hayney, M. S., Henriquez, K. M., Barnet, J. H., Ewers, T., Champion, H. M., Flannery, S., & Barrett, B. P. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.03.003 · Cited by 81 · see citing works
Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
Rotondi, M., Coperchini, F., Latrofa, F., & Chiovato, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00314 · Cited by 77 · see citing works
Self-citationLang, S., Li, L., Wang, X., Sun, J., Xinying, X., Xiao, Y., Zhang, M., Ao, T., & Wang, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169100 · Cited by 72 · see citing works
Role of chemokine receptors in thyroid cancer and immunotherapy
Coperchini, F., Croce, L., Marinò, M., Chiovato, L., & Rotondi, M. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0163 · Cited by 57 · see citing works
Self-citationSpiegel, M., & Weber, F. (2006) · Virology Journal · doi:10.1186/1743-422x-3-17 · Cited by 55 · see citing works
Almansa, R., Sanchez-Garcia, M., Herrero, A., Calzada, S., Roig, V., Barbado, J., Rico, L., Bobillo, F., Bouza, J. M. E., Iglesias, V., et al. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0131 · Cited by 38 · see citing works
Henriquez, K. M., Hayney, M. S., Xie, Y., Zhang, Z., & Barrett, B. P. (2014) · Journal of Medical Virology · doi:10.1002/jmv.24042 · Cited by 36 · see citing works
Küng, E., Coward, W. R., Neill, D. R., Malak, H. A., Mühlemann, K., Kadioglu, A., Hilty, M., & Hathaway, L. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092355 · Cited by 29 · see citing works
What does the peripheral blood tell you in SARS?
Openshaw, P. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02448.x · Cited by 22 · see citing works
Hao, X., Lv, Q., Li, F., Xu, Y., & Gao, H. (2019) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12088 · Cited by 21 · see citing works
The novel chemokine mob-1: Involvement in adult respiratory distress syndrome
Abdullah, F., Ovadia, P., Feuerstein, G., Neville, L. F., Morrison, R., Mathiak, G., Whiteford, M. H., & Rabinovici, R. (1997) · Surgery · doi:10.1016/s0039-6060(97)90022-2 · Cited by 16 · see citing works
Mob-1 expression in IL-2-induced ARDS: regulation by TNF-alpha
Neville, L. F., Abdullah, F. S., McDonnell, P. M., Young, P. R., FEUERSTEIN, G. Z., & Rabinovici, R. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.269.6.l884 · Cited by 14 · see citing works
MOB-1 and TNF-?? Interact to Induce Microvascular Lung Injury
Rabinovici, R., Zhang, D., Su, Y., Xiaoxing, L., Zhao, Q., & Yang, J.-H. (2002) · Shock · doi:10.1097/00024382-200209000-00010 · Cited by 6 · see citing works
Chemokine receptors: interaction with HIV-1 and viral-encoded chemokines
Sozzani, S., Allavena, P., Vecchi, A., Damme, J. V., & Mantovani, A. (2000) · Pharmaceutica Acta Helvetiae · doi:10.1016/s0031-6865(99)00040-0 · Cited by 5 · see citing works
Flagged first, then by citations
4 of the 106 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S. K., Bae, J. H., Kwon, H., & Nauck, M. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,024 · see citing works
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 570 · see citing works
Mazza, M. G., Palladini, M., De Lorenzo, R., Magnaghi, C., Poletti, S., Furlan, R., Ciceri, F., Rovere-Querini, P., & Benedetti, F. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.02.021 · Cited by 513 · see citing works
“T helper (Th)-1 cytokines, including Interleukin (IL)-1β, IL-6, Interferon (IFN)-γ, Tumor Necrosis Factor (TNF)-α, CXCL10, and CCL2; and Th-2 cytokines, including IL-4, IL-10, and IL-1 receptor antagonist are all elevated in the serum of COVID-19 patients (Coperchini et al., 2020) in a “cytokine storm” typically assoc…”
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Shah, V. K., Firmal, P., Alam, A., Ganguly, D., & Chattopadhyay, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01949 · Cited by 471 · see citing works
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
Oladunni, F. S., Park, J.-G., Pino, P., Gonzalez, O., Akhter, A., Allué-Guardia, A., Olmo-Fontánez, A. M., Gautam, S., Garcia-Vilanova, A., Ye, C.-J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19891-7 · Cited by 394 · see citing works
Cascade of immune mechanism and consequences of inflammatory disorders
Megha, K. B., Joseph, X., Akhil, V., & Mohanan, P. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153712 · Cited by 374 · see citing works
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 348 · see citing works
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, S. D. S. G., Soares, V. C., Ferreira, A. C., Sacramento, C. Q., Rodrigues, N. F., Temerozo, J. R., Teixeira, L., da Silva, M. A. N., Barreto, E. A., Mattos, M., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009127 · Cited by 327 · see citing works
The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
Darif, D., Hammi, I., Kihel, A., Saik, I. E. I., Guessous, F., & Akarid, K. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104799 · Cited by 327 · see citing works
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection
Margraf, A., Ludwig, N., Zarbock, A., & Rossaint, J. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005175 · Cited by 304 · see citing works
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 294 · see citing works
Kumar, V. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107087 · Cited by 276 · see citing works
Impact of COVID-19 on the thyroid gland: an update
Scappaticcio, L., Pitoia, F., Esposito, K., Piccardo, A., & Trimboli, P. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09615-z · Cited by 270 · see citing works
Ramaswamy, A., Brodsky, N. N., Sumida, T. S., Comi, M., Asashima, H., Hoehn, K. B., Li, N., Liu, Y., Shah, A. S., Ravindra, N. G., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.003 · Cited by 270 · see citing works
Innate Immune Cell Death in Neuroinflammation and Alzheimer’s Disease
Rajesh, Y., & Kanneganti, T. (2022) · Cells · doi:10.3390/cells11121885 · Cited by 261 · see citing works
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Forchette, L., Sebastian, W., & Liu, T. (2021) · Current Medical Science · doi:10.1007/s11596-021-2395-1 · Cited by 260 · see citing works
Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
Sharma, C., Ganigara, M., Galeotti, C., Burns, J., Berganza, F. M., Hayes, D. A., Singh‐Grewal, D., Bharath, S., Sajjan, S., & Bayry, J. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00709-9 · Cited by 258 · see citing works
Rotondi, M., Coperchini, F., Ricci, G., Denegri, M., Croce, L., Ngnitejeu, S. T., Villani, L., Magri, F., Latrofa, F., & Chiovato, L. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01436-w · Cited by 251 · see citing works
Self-citationCytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis
Wilson, J. G., Simpson, L. J., Ferreira, A.-M., Rustagi, A., Roque, J., Asuni, A., Ranganath, T., Grant, P., Subramanian, A. K., Rosenberg‐Hasson, Y., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140289 · Cited by 250 · see citing works
Chemokines and chemokine receptors during COVID-19 infection
Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 246 · see citing works
Deciphering the COVID‐19 cytokine storm: Systematic review and meta‐analysis
Mulchandani, R., Lyngdoh, T., & Kakkar, A. K. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13429 · Cited by 242 · see citing works
Humoral Responses and Serological Assays in SARS-CoV-2 Infections
Galipeau, Y., Greig, M., Liu, C., Driedger, M., & Langlois, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.610688 · Cited by 239 · see citing works
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Hwang, Y., Lu, R., Su, S.-C., Chiang, P.-Y., Ko, S.-H., Ke, F.-Y., Liang, K.-H., Hsieh, T.-Y., & Wu, H. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-021-00784-w · Cited by 236 · see citing works
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mazza, M. G., Palladini, M., Poletti, S., & Benedetti, F. (2022) · CNS Drugs · doi:10.1007/s40263-022-00931-3 · Cited by 233 · see citing works
Barberis, E., Timo, S., Amede, E., Vanella, V. V., Puricelli, C., Cappellano, G., Raineri, D., Cittone, M. G., Rizzi, E., Pedrinelli, A. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228623 · Cited by 226 · see citing works
Encephalopathy in patients with COVID‐19: A review
Garg, R. K., Paliwal, V. K., & Gupta, A. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26207 · Cited by 224 · see citing works
Vitamin D insufficiency as a potential culprit in critical COVID‐19 patients
Munshi, R., Hussein, M. H., Toraih, E. A., Elshazli, R. M., Jardak, C., Sultana, N., Youssef, M. R., Omar, M., Attia, A. S., Fawzy, M. S., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26360 · Cited by 223 · see citing works
Simadibrata, D. M., Calvin, J., Wijaya, A. D., & Ibrahim, N. A. A. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.01.006 · Cited by 213 · see citing works
COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course
Landstra, C. P., & de Koning, E. J. P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.649525 · Cited by 212 · see citing works
Predictors of COVID-19 severity: a systematic review and meta-analysis
Mudatsir, M., Fajar, J. K., Wulandari, L., Soegiarto, G., Ilmawan, M., Purnamasari, Y., Mahdi, B. A., Jayanto, G. D., Suhendra, S., Setianingsih, Y. A., et al. (2020) · F1000Research · doi:10.12688/f1000research.26186.2 · Cited by 209 · see citing works
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Suryawanshi, R. K., Chen, I. P., Ma, T., Syed, A. M., Brazer, N., Saldhi, P., Simoneau, C. R., Ciling, A., Khalid, M. M., Sreekumar, B. K. N., et al. (2022) · Nature · doi:10.1038/s41586-022-04865-0 · Cited by 208 · see citing works
The glycosylation in SARS-CoV-2 and its receptor ACE2
Gong, Y., Qin, S., Dai, L., & Tian, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00809-8 · Cited by 207 · see citing works
Circulating Exosomes Are Strongly Involved in SARS-CoV-2 Infection
Barberis, E., Vanella, V. V., Falasca, M., Caneparo, V., Cappellano, G., Raineri, D., Ghirimoldi, M., Giorgis, V. D., Puricelli, C., Vaschetto, R., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.632290 · Cited by 200 · see citing works
Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic
Noreen, S., Maqbool, I., & Madni, A. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173854 · Cited by 196 · see citing works
A review of cytokine-based pathophysiology of Long COVID symptoms
Low, R. N., Low, R. J., & Akrami, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1011936 · Cited by 196 · see citing works
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Pyrillou, K., Burzynski, L. C., & Clarke, M. C. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.613170 · Cited by 188 · see citing works
I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People
Pietrobon, A. J., Teixeira, F. M. E., & Sato, M. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.579220 · Cited by 185 · see citing works
Vascular alterations among young adults with SARS-CoV-2
Ratchford, S. M., Stickford, J. L., Province, V. M., Stute, N. L., Augenreich, M. A., Koontz, L. K., Bobo, L. K., & Stickford, A. S. L. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00897.2020 · Cited by 180 · see citing works
Kimhofer, T., Lodge, S., Whiley, L., Gray, N., Loo, R. L., Lawler, N. G., Nitschke, P., Bong, S.-H., MORRISON, D. L., Begum, S., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00519 · Cited by 177 · see citing works
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19
Zhang, Z., Zhang, X., Bi, K., He, Y., Yan, W., Yang, C. S., & Zhang, J. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.05.023 · Cited by 171 · see citing works
Plants Metabolites: Possibility of Natural Therapeutics Against the COVID-19 Pandemic
Bhuiyan, F. R., Howlader, S., Raihan, T., & Hasan, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00444 · Cited by 170 · see citing works
Hoagland, D. A., Møller, R., Uhl, S. A., Oishi, K., Frere, J. J., Golynker, I., Horiuchi, S., Panis, M., Blanco-Melo, D., Sachs, D. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.017 · Cited by 170 · see citing works
Cesta, M. C., Zippoli, M., Marsiglia, C., Gavioli, E. M., Mantelli, F., Allegretti, M., & BALK, R. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.808797 · Cited by 167 · see citing works
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
Singh, S. P., Pritam, M., Pandey, B., & Yadav, T. P. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26254 · Cited by 166 · see citing works
Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review
Burlou-Nagy, C., Bănică, F., Jurca, T., Vicaș, L. G., Marian, E., Muresan, M. E., Bácskay, I., Kiss, R., Fehér, P. S., & Pallag, A. (2022) · Plants · doi:10.3390/plants11091244 · Cited by 165 · see citing works
SARS-CoV-2: characteristics and current advances in research
Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 162 · see citing works
SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip
Guo, Y., Luo, R., Wang, Y., Deng, P., Song, T., Zhang, M., Wang, P., Zhang, X., Cui, K., Tao, T., et al. (2020) · 中国科学通报：英文版 · doi:10.1016/j.scib.2020.11.015 · Cited by 161 · see citing works
Neuropathobiology of COVID-19: The Role for Glia
Tremblay, M.-E., Madore, C., Bordeleau, M., Tian, L., & Verkhratsky, A. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.592214 · Cited by 159 · see citing works
COVID-19: Complement, Coagulation, and Collateral Damage
Lo, M. W., Kemper, C., & Woodruff, T. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000644 · Cited by 158 · see citing works
How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms
Nikbakht, F., Mohammadkhanizadeh, A., & Mohammadi, E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102535 · Cited by 157 · see citing works
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Zhao, N., Di, B., & Xu, L. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.06.002 · Cited by 156 · see citing works
Severely low testosterone in males with COVID‐19: A case‐control study
Salonia, A., Pontillo, M., Capogrosso, P., Gregori, S., Tassara, M. G., Boeri, L., Carenzi, C., Abbate, C., Cignoli, D., Ferrara, A. M., et al. (2021) · Andrology · doi:10.1111/andr.12993 · Cited by 145 · see citing works
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 144 · see citing works
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
Ritter, A., Kreis, N., Louwen, F., & Yuan, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165793 · Cited by 142 · see citing works
Pincemail, J., Cavalier, E., Charlier, C., Cheramy‐Bien, J., Brevers, E., Courtois, A., Fadeur, M., Meziane, S., Goff, C. M. L., Misset, B., et al. (2021) · Antioxidants · doi:10.3390/antiox10020257 · Cited by 140 · see citing works
Efforts at COVID-19 Vaccine Development: Challenges and Successes
Haque, A., & Pant, A. B. (2020) · Vaccines · doi:10.3390/vaccines8040739 · Cited by 139 · see citing works
2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2
Ünal, M. A., Bayrakdar, F., Fusco, L., Beşbinar, Ö., Shuck, C. E., Yalçın, S., Erken, M. T., Özkul, A., Gürcan, C., Panatli, O., et al. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101136 · Cited by 137 · see citing works
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Lee, W., Ahn, J. H., Park, H. H., Kim, H. N., Kim, H., Yoo, Y., Shin, H., Hong, K. S., Jang, J. G., Park, C. G., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00292-7 · Cited by 136 · see citing works
Increased Plasma Heparanase Activity in COVID-19 Patients
Buijsers, B., Yanginlar, C., de Nooijer, A., Grondman, I., Maciej-Hulme, M. L., Jonkman, I., Janssen, N. A. F., Rother, N., de Graaf, M. J. J., Pickkers, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575047 · Cited by 133 · see citing works
Coperchini, F., Chiovato, L., Ricci, G., Croce, L., Magri, F., & Rotondi, M. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.005 · Cited by 133 · see citing works
Self-citationDoes mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?
Orvieto, R., Noach‐Hirsh, M., Segev-Zahav, A., Haas, J., Nahum, R., & Aizer, A. (2021) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-021-00757-6 · Cited by 133 · see citing works
Neurological complications and infection mechanism of SARS-CoV-2
Wan, D., Du, T., Hong, W., Chen, L., Que, H., Lu, S., & Peng, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00818-7 · Cited by 132 · see citing works
Wei, Y., & Shah, R. (2020) · Pharmaceuticals · doi:10.3390/ph13070155 · Cited by 129 · see citing works
Aleebrahim‐Dehkordi, E., Molavi, B., Mokhtari, M., Deravi, N., Fathi, M., Fazel, T., Mohebalizadeh, M., Koochaki, P., Shobeiri, P., & Dehkordi, A. H. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101495 · Cited by 129 · see citing works
Impact of COVID-19 on Cardiovascular Disease
Vosko, I., Zirlik, A., & Bugger, H. (2023) · Viruses · doi:10.3390/v15020508 · Cited by 129 · see citing works
A case‐control study on the association between periodontitis and coronavirus disease (COVID‐19)
Anand, P. S., Jadhav, P., Kamath, K. P., Kumar, S. R., Vijayalaxmi, S., & Anil, S. (2022) · Journal of Periodontology · doi:10.1002/jper.21-0272 · Cited by 126 · see citing works
Castelli, V., Cimini, A., & Ferri, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02132 · Cited by 126 · see citing works
Vitamin D deficiency and co-morbidities in COVID-19 patients – A fatal relationship?
Biesalski, H. K. (2020) · NFS Journal · doi:10.1016/j.nfs.2020.06.001 · Cited by 125 · see citing works
Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection?
Haggag, Y. A., El‐Ashmawy, N. E., & Okasha, K. M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109957 · Cited by 125 · see citing works
From causes of aging to death from COVID-19
Blagosklonny, M. V. (2020) · Aging · doi:10.18632/aging.103493 · Cited by 123 · see citing works
Morais, A. H. D. A., Aquino, J. D. S., da Silva-Maia, J. K., Vale, S. H. D. L., Maciel, B. L. L., & Passos, T. S. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003311 · Cited by 123 · see citing works
Late Complications of COVID-19; a Systematic Review of Current Evidence.
SeyedAlinaghi, S., Afsahi, A. M., MohsseniPour, M., Behnezhad, F., Salehi, M. A., Barzegary, A., Mirzapour, P., Mehraeen, E., & Dadras, O. (2021) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v9i1.1058 · Cited by 121 · see citing works
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, N., Chastain, W. H., Paz, M., Solch-Ottaiano, R. J., Murray-Brown, I. C., Befeler, J. B., Gressett, T. E., Longo, M. T., Engler-Chiurazzi, E. B., & Bix, G. J. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.02.002 · Cited by 122 · see citing works
Thyroid hormone concentrations in severely or critically ill patients with COVID-19
Gao, W., Guo, W., Guo, Y., Shi, M., Dong, G., Wang, G., Ge, Q., Zhu, J. H., & Zhou, X. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01460-w · Cited by 117 · see citing works
Small molecules in the treatment of COVID-19
Lei, S., Chen, X., Wu, J., Duan, X., & Men, K. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01249-8 · Cited by 117 · see citing works
Dissecting lipid metabolism alterations in SARS-CoV-2
Casari, I., Manfredi, M., Metharom, P., & Falasca, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101092 · Cited by 116 · see citing works
Coperchini, F., Chiovato, L., & Rotondi, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668507 · Cited by 116 · see citing works
Self-citationThye, A. Y.-K., Law, J. W., Tan, L. T., Pusparajah, P., Ser, H., Thurairajasingam, S., Letchumanan, V., & Lee, L. (2022) · Biology · doi:10.3390/biology11010061 · Cited by 115 · see citing works
A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Yekedüz, E., Utkan, G., & Ürün, Y. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.09.028 · Cited by 114 · see citing works
Holmes, E. C., Wist, J., Masuda, R., Lodge, S., Nitschke, P., Kimhofer, T., Loo, R. L., Begum, S., Boughton, B. A., Yang, R., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00224 · Cited by 113 · see citing works
The Effect of Bacterial Infections, Probiotics and Zonulin on Intestinal Barrier Integrity
Serek, P., & Oleksy-Wawrzyniak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111359 · Cited by 113 · see citing works
Amor, S., Blanco, L. F., & Baker, D. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13523 · Cited by 112 · see citing works
Du, J., Liao, W., Liu, W., Deb, D. K., He, L., Hsu, P. J., Nguyen, T., Zhang, L., Bissonnette, M., He, C., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.10.023 · Cited by 112 · see citing works
Name, J. J., Souza, A. C. R., Vasconcelos, A. R., Prado, P. S., & Pereira, C. P. M. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.606398 · Cited by 112 · see citing works
Targeting inflammation and cytokine storm in COVID-19
Huang, Q., Wu, X., Zheng, X., Luo, S., Xu, S., & Weng, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105051 · Cited by 111 · see citing works
Bearse, M., Hung, Y. P., Krauson, A. J., Bonanno, L., Boyraz, B., Harris, C. K., Helland, T. L., Hilburn, C. F., Hutchison, B. M., Jobbagy, S., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00790-1 · Cited by 111 · see citing works
Haematological manifestations of COVID‐19: From cytopenia to coagulopathy
Agbuduwe, C., & Basu, S. (2020) · European Journal Of Haematology · doi:10.1111/ejh.13491 · Cited by 110 · see citing works
Root-Bernstein, R. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042108 · Cited by 110 · see citing works
SARS-CoV-2 Causes Severe Epithelial Inflammation and Barrier Dysfunction
Deinhardt‐Emmer, S., Böttcher, S., Häring, C., Giebeler, L. N., Henke, A., Zell, R., Jungwirth, J., Jordan, P. M., Werz, O., Hornung, F., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00110-21 · Cited by 109 · see citing works
Probiotics: A potential immunomodulator in COVID-19 infection management
Singh, K., & Rao, A. (2021) · Nutrition Research · doi:10.1016/j.nutres.2020.12.014 · Cited by 109 · see citing works
Udomsinprasert, W., Jittikoon, J., Sangroongruangsri, S., & Chaikledkaew, U. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00899-z · Cited by 108 · see citing works
SARS‐CoV‐2‐specific virulence factors in COVID‐19
Kumar, A., Prasoon, P., Kumari, C., Pareek, V., Faiq, M. A., Narayan, R. K., Kulandhasamy, M., & Kant, K. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26615 · Cited by 107 · see citing works
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
Lokhande, A. S., & Devarajan, P. V. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173748 · Cited by 107 · see citing works
Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study
Huang, D., Lin, S., He, J., Wang, Q., & Zhan, Y. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28008 · Cited by 107 · see citing works
Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations
Słomka, A., Kowalewski, M., & Żekanowska, E. (2020) · Pathogens · doi:10.3390/pathogens9060493 · Cited by 106 · see citing works
COVID-19, cytokines, inflammation, and spices: How are they related?
Kunnumakkara, A. B., Rana, V., Parama, D., Banik, K., Girisa, S., Henamayee, S., Thakur, K. K., Dutta, U., Garodia, P., Gupta, S. C., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119201 · Cited by 105 · see citing works
Magnesium in Infectious Diseases in Older People
Dominguez, L. J., Veronese, N., Guerrero‐Romero, F., & Barbagallo, M. (2021) · Nutrients · doi:10.3390/nu13010180 · Cited by 104 · see citing works
Lung microbiome and coronavirus disease 2019 (COVID-19): Possible link and implications
Khatiwada, S., & Subedi, A. (2020) · Human Microbiome Journal · doi:10.1016/j.humic.2020.100073 · Cited by 103 · see citing works
Biomarkers of post-covid depression
Lorkiewicz, P., & Waszkiewicz, N. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184142 · Cited by 102 · see citing works
Zhao, H., Zhu, Q., Zhang, C., Li, J., Wei, M., Qin, Y., Chen, G., Wang, K., Yu, J., Wu, Z., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110825 · Cited by 101 · see citing works
- Authors
- Coperchini, F., Chiovato, L., Croce, L., Magri, F., & Rotondi, M.
- Affiliations
- Istituti Clinici Scientifici Maugeri (IT)
- University of Pavia (IT)
- Corresponding author
- Rotondi, Mario
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 53
- Pages
- 25-32
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7211650
- OpenAlex
- W3021577619
- Cited by
- 1,288
- References
- 106
- Citations by year
- 2026: 20 · 2025: 44 · 2024: 92 · 2023: 158 · 2022: 274 · 2021: 443 · 2020: 257
- FWCI
- 13.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- cytokine storm, COVID-19 pandemic, SARS-CoV-2, chemokines, chemokine receptors, acute respiratory distress syndrome, systemic inflammation, immune cell recruitment, SARS, MERS, betacoronaviruses, disease severity
- MeSH terms
- Betacoronavirus, Cytokine Release Syndrome, COVID-19, SARS-CoV-2, Humans, Pneumonia, Viral, Coronavirus Infections, Chemokines, Receptors, Chemokine, Severe Acute Respiratory Syndrome, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
